These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 39340434)
1. Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients. Liu J; Wu H; Wang Q; Jin S; Hou S; Shen Z; Zhao L; Xu S; Pang D Cancer Control; 2024; 31():10732748241288118. PubMed ID: 39340434 [TBL] [Abstract][Full Text] [Related]
2. Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis. Tang M; Rong Y; Li X; Pan H; Tao P; Wu Z; Liu S; Tang R; Liu Z; Cai H BMC Cancer; 2024 Sep; 24(1):1163. PubMed ID: 39300389 [TBL] [Abstract][Full Text] [Related]
3. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes. Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237 [TBL] [Abstract][Full Text] [Related]
4. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma. He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968 [TBL] [Abstract][Full Text] [Related]
5. Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis-related genes in colorectal cancer. Zhai X; Chen B; Hu H; Deng Y; Chen Y; Hong Y; Ren X; Jiang C Cancer Med; 2024 May; 13(10):e7315. PubMed ID: 38785271 [TBL] [Abstract][Full Text] [Related]
6. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
7. Anoikis-related subtype and prognosis analyses based on bioinformatics, and an expression verification of ANGPTL4 based on experiments of lung adenocarcinoma. Shen X; Xie J; Liu S; Cai Y; Yuan S; Uehara Y; Zhu D; Zheng M J Thorac Dis; 2024 Aug; 16(8):5361-5378. PubMed ID: 39268091 [TBL] [Abstract][Full Text] [Related]
8. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma. Zhang X; Wen Z; Wang Q; Ren L; Zhao S Front Immunol; 2023; 14():1199869. PubMed ID: 37575253 [TBL] [Abstract][Full Text] [Related]
9. Development of an anoikis-related gene signature and prognostic model for predicting the tumor microenvironment and response to immunotherapy in colorectal cancer. Li C; Weng J; Yang L; Gong H; Liu Z Front Immunol; 2024; 15():1378305. PubMed ID: 38779664 [TBL] [Abstract][Full Text] [Related]
10. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer. Wang Z; Liu H; Gong Y; Cheng Y Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948 [TBL] [Abstract][Full Text] [Related]
11. Identifying subtypes and developing prognostic models based on N6-methyladenosine and immune microenvironment related genes in breast cancer. Wang L; Li J; Mei N; Chen H; Niu L; He J; Wang R Sci Rep; 2024 Jul; 14(1):16586. PubMed ID: 39020010 [TBL] [Abstract][Full Text] [Related]
12. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings. Zhu S; Zhao Q; Fan Y; Tang C BMC Urol; 2023 Dec; 23(1):199. PubMed ID: 38049825 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma. Diao X; Guo C; Li S Thorac Cancer; 2023 Jan; 14(3):320-330. PubMed ID: 36507553 [TBL] [Abstract][Full Text] [Related]
14. A novel anoikis-related gene signature predicts prognosis in patients with breast cancer and reveals immune infiltration. Tang C; Qin L; Li J Medicine (Baltimore); 2023 Oct; 102(43):e35732. PubMed ID: 37904416 [TBL] [Abstract][Full Text] [Related]
15. A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer. Song Z; Gui S; Xiao S; Rao X; Cong N; Deng H; Yu Z; Zeng T Sci Rep; 2024 Feb; 14(1):3198. PubMed ID: 38332160 [TBL] [Abstract][Full Text] [Related]
16. Prognostic analyses of genes associated with anoikis in breast cancer. Cao J; Ma X; Zhang G; Hong S; Ma R; Wang Y; Yan X; Ma M PeerJ; 2023; 11():e15475. PubMed ID: 37842046 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value and Immune Signatures of Anoikis-related Genes in Breast Cancer. Wu Q; Luo Y; Lin N; Zheng S; Xie X J Immunother; 2024 Oct; 47(8):328-341. PubMed ID: 38864225 [TBL] [Abstract][Full Text] [Related]
18. Deciphering anoikis resistance and identifying prognostic biomarkers in clear cell renal cell carcinoma epithelial cells. Li J; Cao Q; Tong M Sci Rep; 2024 May; 14(1):12044. PubMed ID: 38802480 [TBL] [Abstract][Full Text] [Related]
19. PANoptosis-related molecular clustering and prognostic signature associated with the immune landscape and therapy response in breast cancer. Cao Y; Guan L; Yang L; Wei C Medicine (Baltimore); 2024 Sep; 103(37):e39511. PubMed ID: 39287311 [TBL] [Abstract][Full Text] [Related]
20. A novel anoikis-related risk model predicts prognosis in patients with colorectal cancer and responses to different immunotherapy strategies. Yang L; Xu F J Cancer Res Clin Oncol; 2023 Sep; 149(12):10879-10892. PubMed ID: 37318595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]